Economics at the FTC: Hospital Mergers, Authorized Generic Drugs, and Consumer Credit Markets

Economists at the Federal Trade Commission pursue the agency's competition and consumer protection missions. In this year's essay, in antitrust, we discuss various aspects of our hospital merger analyses as well as the effects of authorized generic drugs on consumers and competition. In co...

Full description

Saved in:
Bibliographic Details
Published in:Review of industrial organization 2011-12, Vol.39 (4), p.271-296
Main Authors: Farrell, Joseph, Balan, David J., Brand, Keith, Wendling, Brett W.
Format: Article
Language:English
Subjects:
Acquisitions & mergers
Agreements
Anti-trust legislation
Antitrust
Bargaining
Brands
Competition
Consumer behavior
Consumer credit
Consumer protection
Consumers
Credit
Credit bureaus
Credit insurance
Credit reports
Drugs
Economics
Economics and Finance
Economists
Equilibrium
Generic drugs
Generic products
Government departments
Homeowners insurance
Hospital costs
Hospital management
Hospitals
Industrial Organization
Insurance
Market prices
Markets
Mergers
Microeconomics
Modeling
Monopoly
Pharmaceuticals
Political economy
Prices
Studies
U.S.A
United States Federal trade commission
Websites
Wholesale prices
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Economists at the Federal Trade Commission pursue the agency's competition and consumer protection missions. In this year's essay, in antitrust, we discuss various aspects of our hospital merger analyses as well as the effects of authorized generic drugs on consumers and competition. In consumer protection, we describe two ongoing studies on the use of credit-based insurance scores to price homeowners insurance, and the accuracy of consumers' credit reports that are provided by credit bureaus.
ISSN:0889-938X
1573-7160
DOI:10.1007/s11151-011-9320-x